SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Qiushi Chen, Turgay Ayer, Loretta J. Nastoupil, Adam C. Rose, Christopher R. Flowers, Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicular Lymphoma, Value in Health, 2015, 18, 2, 189

    CrossRef

  2. 2
    Antonia Dimitrakopoulou-Strauss, PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome, Future Oncology, 2015, 11, 7, 1083

    CrossRef

  3. 3
    Loretta J. Nastoupil, Rajni Sinha, Michelle Byrtek, Ryan Ziemiecki, Michael Taylor, Jonathan W. Friedberg, Jean L. Koff, Brian K. Link, James R. Cerhan, Keith L. Dawson, Christopher R. Flowers, Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States, Leukemia & Lymphoma, 2014, 1

    CrossRef

  4. 4
    Judith Neumaier, Lohnt sich die Erhaltungstherapie mit Rituximab beim follikulären Lymphom?, Im Focus Onkologie, 2014, 17, 9, 20

    CrossRef

  5. 5
    Satyajit S Mohite, Loretta J Nastoupil, Rituximab in follicular lymphoma: the first chapter of the new era?, International Journal of Hematologic Oncology, 2014, 3, 4, 267

    CrossRef